Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase

被引:42
作者
Menear, Keith A. [1 ]
Adcock, Claire [1 ]
Alonso, Francisco Cuenca [1 ]
Blackburn, Kristel [1 ]
Copsey, Louise [1 ]
Drzewiecki, Jan [1 ]
Fundo, Alexandra [1 ]
Le Gall, Armelle [1 ]
Gomez, Sylvie [1 ]
Javaid, Hashim [1 ]
Lence, Carlos Fenandez [1 ]
Martin, Niall M. B. [1 ]
Mydlowski, Chris [1 ]
Smith, Graeme C. M. [1 ]
机构
[1] KuDos Pharmaceut Ltd, Cambridge CB4 0PE, England
关键词
poly(ADP-ribose) polymerase-1; PARP-1; PARP-2;
D O I
10.1016/j.bmcl.2008.06.025
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We have previously described poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors based on a substituted benzyl-phthalazinone scaffold. As an alternative chemical template, a novel series of alkoxybenzamides were developed with restricted conformation through intramolecular hydrogen bond formation; the compounds exhibit low nM enzyme and cellular activity as PARP-1 inhibitors. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3942 / 3945
页数:4
相关论文
共 11 条
[1]   Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase [J].
Bryant, HE ;
Schultz, N ;
Thomas, HD ;
Parker, KM ;
Flower, D ;
Lopez, E ;
Kyle, S ;
Meuth, M ;
Curtin, NJ ;
Helleday, T .
NATURE, 2005, 434 (7035) :913-917
[2]   HYDROGEN-PEROXIDE INSULT IN CULTURED MAMMALIAN-CELLS - RELATIONSHIPS BETWEEN DNA SINGLE-STRAND BREAKAGE, POLY(ADP-RIBOSE) METABOLISM AND CELL KILLING [J].
CANTONI, O ;
CATTABENI, F ;
STOCCHI, V ;
MEYN, RE ;
CERUTTI, P ;
MURRAY, D .
BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 1014 (01) :1-7
[3]   Phthalazinones 2: Optimisation and synthesis of novel potent inhibitors of poly(ADP-ribose)polymerase [J].
Cockcroft, XL ;
Dillon, KJ ;
Dixon, L ;
Drzewiecki, J ;
Kerrigan, F ;
Loh, VM ;
Martin, NMB ;
Menear, KA ;
Smith, GCM .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (04) :1040-1044
[4]   Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy [J].
Farmer, H ;
McCabe, N ;
Lord, CJ ;
Tutt, ANJ ;
Johnson, DA ;
Richardson, TB ;
Santarosa, M ;
Dillon, KJ ;
Hickson, I ;
Knights, C ;
Martin, NMB ;
Jackson, SP ;
Smith, GCM ;
Ashworth, A .
NATURE, 2005, 434 (7035) :917-921
[5]  
GRIFFIN RJ, 1995, ANTI-CANCER DRUG DES, V10, P507
[6]  
HOEIJMAKERS JH, 2005, NATURE, V434, P917
[7]   Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors [J].
Jagtap, P ;
Szabó, C .
NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (05) :421-440
[8]   Phthalazinones. Part 1: The design and synthesis of a novel series of potent inhibitors of poly(ADP-ribose)polymerase [J].
Loh, VM ;
Cockcroft, XL ;
Dillon, KJ ;
Dixon, L ;
Drzewiecki, J ;
Everlsey, PJ ;
Gomez, S ;
Hoare, J ;
Kerrigan, F ;
Matthews, ITW ;
Menear, KA ;
Martin, NMB ;
Newton, RF ;
Paul, J ;
Smith, GCM ;
Vile, J ;
Whittle, AJ .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (09) :2235-2238
[9]   Tricyclic benzimidazoles as potent poly(ADP-ribose) polymerase-1 inhibitors [J].
Skalitzky, DJ ;
Marakovits, JT ;
Maegley, KA ;
Ekker, A ;
Yu, XH ;
Hostomsky, Z ;
Webber, SE ;
Eastman, BW ;
Almassy, R ;
Li, JK ;
Curtin, NJ ;
Newell, DR ;
Calvert, AH ;
Griffin, RJ ;
Golding, BT .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (02) :210-213
[10]   Endothelial dysfunction in a rat model of endotoxic shock - Importance of the activation of poly(ADP-ribose) synthetase by peroxynitrite [J].
Szabo, C ;
Cuzzocrea, S ;
Zingarelli, B ;
OConnor, M ;
Salzman, AL .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (03) :723-735